These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 34062992)

  • 21. Anticancer nanomedicines harnessing tumor microenvironmental components.
    Li Y; Chen Z; Gu L; Duan Z; Pan D; Xu Z; Gong Q; Li Y; Zhu H; Luo K
    Expert Opin Drug Deliv; 2022 Apr; 19(4):337-354. PubMed ID: 35244503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoparticles Targeting and Remodeling Tumor Microenvironment for Cancer Theranostics.
    Lin G; Chen S; Mi P
    J Biomed Nanotechnol; 2018 Jul; 14(7):1189-1207. PubMed ID: 29944095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accurate programmed multifunctional nano-missiles for self-promoted deep delivery and synergistic cascade tumor therapy: Tactfully collaborating chemosynthesis with tumor microenvironment remodeling.
    Lu R; Wang S; Yang Z; Zhou L; Yang C; Wu Y
    Theranostics; 2022; 12(12):5299-5316. PubMed ID: 35910803
    [No Abstract]   [Full Text] [Related]  

  • 24. The Intracellular and Extracellular Microenvironment of Tumor Site: The Trigger of Stimuli-Responsive Drug Delivery Systems.
    Jing X; Hu H; Sun Y; Yu B; Cong H; Shen Y
    Small Methods; 2022 Mar; 6(3):e2101437. PubMed ID: 35048560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
    Sa P; Sahoo SK; Dilnawaz F
    Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer Immunotherapy with "Vascular-Immune" Crosstalk as Entry Point: Associated Mechanisms, Therapeutic Drugs and Nano-Delivery Systems.
    Jiang Z; Fang Z; Hong D; Wang X
    Int J Nanomedicine; 2024; 19():7383-7398. PubMed ID: 39050878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tackling TAMs for Cancer Immunotherapy: It's Nano Time.
    Yang Y; Guo J; Huang L
    Trends Pharmacol Sci; 2020 Oct; 41(10):701-714. PubMed ID: 32946772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural Biology of the Tumor Microenvironment.
    Freeman JW
    Adv Exp Med Biol; 2021; 1350():91-100. PubMed ID: 34888845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment.
    Xu M; Li S
    Cancer Lett; 2023 Oct; 574():216397. PubMed ID: 37730105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy.
    Chen Z; Wang X; Zhao N; Chen H; Guo G
    Expert Opin Drug Deliv; 2023; 20(11):1623-1642. PubMed ID: 38059646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy.
    Truffi M; Mazzucchelli S; Bonizzi A; Sorrentino L; Allevi R; Vanna R; Morasso C; Corsi F
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimuli-responsive charge-reversal nano drug delivery system: The promising targeted carriers for tumor therapy.
    Fang Z; Pan S; Gao P; Sheng H; Li L; Shi L; Zhang Y; Cai X
    Int J Pharm; 2020 Feb; 575():118841. PubMed ID: 31812795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TME-Related Biomimetic Strategies Against Cancer.
    Peng C; Xu Y; Wu J; Wu D; Zhou L; Xia X
    Int J Nanomedicine; 2024; 19():109-135. PubMed ID: 38192633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
    Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor microenvironment-induced structure changing drug/gene delivery system for overcoming delivery-associated challenges.
    Zhang M; Guo X; Wang M; Liu K
    J Control Release; 2020 Jul; 323():203-224. PubMed ID: 32320817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 37. Collagenase-Encapsulated pH-Responsive Nanoscale Coordination Polymers for Tumor Microenvironment Modulation and Enhanced Photodynamic Nanomedicine.
    Liu J; Tian L; Zhang R; Dong Z; Wang H; Liu Z
    ACS Appl Mater Interfaces; 2018 Dec; 10(50):43493-43502. PubMed ID: 30468076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesoporous nanodrug delivery system: a powerful tool for a new paradigm of remodeling of the tumor microenvironment.
    Hang Y; Liu Y; Teng Z; Cao X; Zhu H
    J Nanobiotechnology; 2023 Mar; 21(1):101. PubMed ID: 36945005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology.
    Ma J; Dai L; Yu J; Cao H; Bao Y; Hu J; Zhou L; Yang J; Sofia A; Chen H; Wu F; Xie Z; Qian W; Zhan R
    Biomaterials; 2023 Apr; 295():122026. PubMed ID: 36731366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update on dual targeting strategy for cancer treatment.
    Taghipour YD; Zarebkohan A; Salehi R; Rahimi F; Torchilin VP; Hamblin MR; Seifalian A
    J Control Release; 2022 Sep; 349():67-96. PubMed ID: 35779656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.